With the five-year grant, the consortium hopes to build an initial network of 35 Alzheimer’s disease trial sites at universities across the U.S. The new infrastructure will implement more efficient methods to recruit participants for clinical trials and provide more convenient locations for these patients. The three researchers will collaborate by sharing data, instruments, software and biologic samples.
“Scientists have made great strides in understanding Alzheimer’s disease, and technological advances have placed us on the verge of a breakthrough. This collaboration will remove some of the barriers that have hamstrung researchers from timely completion of clinical trials in Alzheimer’s disease and other dementias,” said Paul Aisen, a principle investigator of the NIH grant and director of the USC Alzheimer’s Therapeutic Research Institute.
More articles on population health:
Medicaid recipients report poorer health than uninsured: 6 findings
Number of Americans with Alzheimer’s to more than double by 2060
Why population health is an AI problem
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
